Description
A long-acting β2-adrenergic receptor agonist (EC50 = 8.71 nM for increasing intracellular cAMP levels in vitro); selective for β2-ARs over β1- and β3-ARs (Kis = 43.6, 616.6, and 3,311.3 nM, respectively); inhibits 5-HT-induced bronchoconstriction in conscious guinea pigs with a maximal effect of 85% at 6.7 µg/kg intratracheally; inhibits methacholine-induced bronchoconstriction in rhesus monkeys with a maximal effect of 75% at 12.5 mg/kg via nebulization
Formal name: 5-[(1R )-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy 2(1H )-quinolinone
Synonyms: QAB149
Molecular weight: 392.5
CAS: 312753-06-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Immunology & Inflammation|Pulmonary Diseases|COPD/Emphysema